Adverse events663

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 663

Type	Event	Organ system	Group	Affected	At risk	Events
other	Nausea	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	36	61	98
other	Nausea	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	31	59	78
other	Nausea	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	40	62	137
other	Stomatitis	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	27	61	85
other	Stomatitis	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	28	59	77
other	Stomatitis	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	30	62	83
other	Vomiting	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	28	61	66
other	Vomiting	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	24	59	55
other	Vomiting	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	28	62	96
other	Diarrhoea	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	23	61	45
other	Diarrhoea	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	27	59	60
other	Diarrhoea	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	24	62	65
other	Constipation	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	23	61	43
other	Constipation	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	22	59	37
other	Constipation	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	24	62	36
other	Dysphagia	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	5	61	11
other	Dysphagia	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	7	59	10
other	Dysphagia	Gastrointestinal disorders	Cetuximab+5-FU+Cisplatin	8	62	12
other	Dyspepsia	Gastrointestinal disorders	Cilengitide 2000 mg Once Weekly+Cetuximab+5-FU+Cisplatin	6	61	6
other	Dyspepsia	Gastrointestinal disorders	Cilengitide 2000 mg Twice Weekly+Cetuximab+5-FU+Cisplatin	3	59	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00705016/events

API reference For AI assistants

Adverse events663

Sources 3

Read this list from software.